Cellectar, Inc.
Records under this name other than the patents Cellectar, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
Showing 1 to 5 of 5 · Back to Cellectar, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,632,644 | Imaging and selective retention of phospholipid ether analogs Term ended Term ended Jul 1, 2026 · From the USPTO record | Term ended | Term ended Jul 1, 2026 | From the USPTO record |
| US 9,550,002 | Phospholipid analogs as diapeutic agents and methods thereof Term ended Term ended Dec 23, 2025 · From the USPTO record | Term ended | Term ended Dec 23, 2025 | From the USPTO record |
| US 9,579,406 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof Term ended Term ended Dec 17, 2025 · From the USPTO record | Term ended | Term ended Dec 17, 2025 | From the USPTO record |
| US 8,877,159 | Phospholipid analogs as diapeutic agents and methods thereof Term ended Ended no later than Mar 2, 2025 · From the USPTO record | Term ended | Ended no later than Mar 2, 2025 | From the USPTO record |
| US 8,877,160 | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof Term ended Ended no later than Mar 2, 2025 · From the USPTO record | Term ended | Ended no later than Mar 2, 2025 | From the USPTO record |